Akari Therapeutics (AKTX) Change in Cash (2014 - 2026)

Akari Therapeutics (AKTX) reported Change in Cash of -$2.4 million for Q1 2026, down 14223.53% on a YoY basis from N/an in Q1 2025, and down 189.55% sequentially from $2.7 million in Q4 2025.

Akari Therapeutics (AKTX) Change in Cash (2014 - 2026) Analysis & Trends

Akari Therapeutics (AKTX) has 9 years of Change in Cash data on file, last reported at -$2.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Cash fell 14223.53% year-over-year to -$2.4 million; the trailing twelve-month figure through Mar 2026 stood at $186000.0 (down 86.04% YoY), and the FY2025 full-year result was $2.6 million, up 319.56% from the prior year.
  • Change in Cash slipped to -$2.4 million in Q1 2026, from $2.7 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $2.9 million in Q2 2024 to a low of -$4.4 million in Q2 2023.
  • A 4-year average of -$801692.3 and a median of -$886000.0 in 2023 frame the typical range for Change in Cash.
  • Across the five-year window, Change in Cash soared 558.35% in 2025 and plunged 14223.53% in 2026, its largest moves.
  • Tracing AKTX's Change in Cash over 4 years: stood at -$886000.0 in 2023, then jumped by 146.61% to $413000.0 in 2024, then soared by 558.35% to $2.7 million in 2025, then tumbled by 189.55% to -$2.4 million in 2026.
  • Business Quant data shows AKTX's Change in Cash at -$2.4 million in Q1 2026, $2.7 million in Q4 2025, and -$227000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -22.03 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -2.44 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 243.78 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 417.10 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -153.10 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 57.19 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 53.61 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.44 Mn
Dec 31, 2025 2.72 Mn
Sep 30, 2025 -227,000.00
Jun 30, 2025 129,000.00
Mar 31, 2025 -17,000.00
Dec 31, 2024 413,000.00
Sep 30, 2024 -1.93 Mn
Jun 30, 2024 2.87 Mn
Mar 31, 2024 -2.54 Mn
Dec 31, 2023 -886,000.00
Sep 30, 2023 -2.45 Mn
Jun 30, 2023 -4.40 Mn
Mar 31, 2023 -1.67 Mn
Dec 31, 2020 1.74 Mn
Sep 30, 2020 -428,468.00
Jun 30, 2020 4.92 Mn
Mar 31, 2020 2.09 Mn
Dec 31, 2019 -536,976.00
Sep 30, 2019 3.51 Mn
Jun 30, 2019 -3.54 Mn